Cargando…

378 Aspirin Desensitization Treatment: A Case Report

BACKGROUND: Aspirin (ASA) is one of the best known and most widely used drugs in the world. Patients with coronary artery disease require prolonged treatments with this drug, which is denied to those patients with histories of adverse reactions to it. METHODS: In a rapid desensitization protocol a p...

Descripción completa

Detalles Bibliográficos
Autores principales: Alvarez, Mirta, Osoria, Lludenich, Ronquillo, Mercedes, Castro, Raúl, Perez, Doguerti, Rodríguez, José, Irarragorri, Catalina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization Journal 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512591/
http://dx.doi.org/10.1097/01.WOX.0000412141.81425.8b
_version_ 1782251755763924992
author Alvarez, Mirta
Osoria, Lludenich
Ronquillo, Mercedes
Castro, Raúl
Perez, Doguerti
Rodríguez, José
Irarragorri, Catalina
author_facet Alvarez, Mirta
Osoria, Lludenich
Ronquillo, Mercedes
Castro, Raúl
Perez, Doguerti
Rodríguez, José
Irarragorri, Catalina
author_sort Alvarez, Mirta
collection PubMed
description BACKGROUND: Aspirin (ASA) is one of the best known and most widely used drugs in the world. Patients with coronary artery disease require prolonged treatments with this drug, which is denied to those patients with histories of adverse reactions to it. METHODS: In a rapid desensitization protocol a patient with a history of ASA-induced urticaria-angioedema was treated with escalating doses of aspirin administered orally every 25 minutes. RESULTS: The patient completed the desensitization protocol in few hours without complications, and currently is able to take 125 mg of ASA per day without adverse reactions. CONCLUSIONS: This report describes the first desensitization treatment with aspirin carried out in our hospital. No other case was found in the national bibliography.
format Online
Article
Text
id pubmed-3512591
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher World Allergy Organization Journal
record_format MEDLINE/PubMed
spelling pubmed-35125912012-12-21 378 Aspirin Desensitization Treatment: A Case Report Alvarez, Mirta Osoria, Lludenich Ronquillo, Mercedes Castro, Raúl Perez, Doguerti Rodríguez, José Irarragorri, Catalina World Allergy Organ J Abstracts of the XXII World Allergy Congress BACKGROUND: Aspirin (ASA) is one of the best known and most widely used drugs in the world. Patients with coronary artery disease require prolonged treatments with this drug, which is denied to those patients with histories of adverse reactions to it. METHODS: In a rapid desensitization protocol a patient with a history of ASA-induced urticaria-angioedema was treated with escalating doses of aspirin administered orally every 25 minutes. RESULTS: The patient completed the desensitization protocol in few hours without complications, and currently is able to take 125 mg of ASA per day without adverse reactions. CONCLUSIONS: This report describes the first desensitization treatment with aspirin carried out in our hospital. No other case was found in the national bibliography. World Allergy Organization Journal 2012-02-17 /pmc/articles/PMC3512591/ http://dx.doi.org/10.1097/01.WOX.0000412141.81425.8b Text en Copyright © 2012 by World Allergy Organization
spellingShingle Abstracts of the XXII World Allergy Congress
Alvarez, Mirta
Osoria, Lludenich
Ronquillo, Mercedes
Castro, Raúl
Perez, Doguerti
Rodríguez, José
Irarragorri, Catalina
378 Aspirin Desensitization Treatment: A Case Report
title 378 Aspirin Desensitization Treatment: A Case Report
title_full 378 Aspirin Desensitization Treatment: A Case Report
title_fullStr 378 Aspirin Desensitization Treatment: A Case Report
title_full_unstemmed 378 Aspirin Desensitization Treatment: A Case Report
title_short 378 Aspirin Desensitization Treatment: A Case Report
title_sort 378 aspirin desensitization treatment: a case report
topic Abstracts of the XXII World Allergy Congress
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3512591/
http://dx.doi.org/10.1097/01.WOX.0000412141.81425.8b
work_keys_str_mv AT alvarezmirta 378aspirindesensitizationtreatmentacasereport
AT osorialludenich 378aspirindesensitizationtreatmentacasereport
AT ronquillomercedes 378aspirindesensitizationtreatmentacasereport
AT castroraul 378aspirindesensitizationtreatmentacasereport
AT perezdoguerti 378aspirindesensitizationtreatmentacasereport
AT rodriguezjose 378aspirindesensitizationtreatmentacasereport
AT irarragorricatalina 378aspirindesensitizationtreatmentacasereport